Literature DB >> 11843212

Acne inversa (alias hidradenitis suppurativa).

I Jansen1, P Altmeyer, G Piewig.   

Abstract

Acne inversa is a recurrent, suppurative disease manifested by abscesses, fistulas, and scarring. Once considered to be a disease of the apocrine glands, it is actually a defect of follicular epithelium. Thus, the term hidradenitis suppurativa is a misnomer and should be abandoned. In cases of familial acne inversa, the pattern of transmission and number of affected individuals are consistent with autosomal dominant inheritance. Aetiological factors such as hyperandrogenism, obesity, smoking and chemical irritants are not consistently associated with the affection. Bacterial involvement is not a primary event in acne inversa, but is secondary to the disease process. Potential complications include dermal contraction, local or systemic infection due to the spread of microorganisms, systemic amyloidosis, arthropathy, and squamous cell carcinoma. As spontaneous resolution is rare and progressive disability is the rule, early definitive surgical intervention is advisable. The surgical procedure of choice in most cases is wide local excision and healing by secondary intention. Pharmacotherapeutic drugs, including synthetic retinoids and antiandrogens, do not prevent progression of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843212     DOI: 10.1046/j.1468-3083.2001.00303.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  11 in total

1.  [Acne inversa].

Authors:  A Stein; G Sebastian
Journal:  Hautarzt       Date:  2003-02       Impact factor: 0.751

Review 2.  [Surgical management of acne inversa].

Authors:  G Weyandt
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 3.  [Clinical variants of acne].

Authors:  T Jansen; S Grabbe; G Plewig
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 4.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

5.  Anoperineal disease in Hidradenitis Suppurativa : MR imaging distinction from perianal Crohn's disease.

Authors:  Louise Monnier; Anthony Dohan; Nedjoua Amara; Anne-Marie Zagdanski; Moustapha Drame; Philippe Soyer; Christine Hoeffel
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

6.  Aerobic and Anaerobic Bacteriology of Hidradenitis Suppurativa: A Study of 22 Cases.

Authors:  Alexandros C Katoulis; Dimitra Koumaki; Aikaterini I Liakou; Georgia Vrioni; Vasiliki Koumaki; Dimitra Kontogiorgi; Korina Tzima; Athanasios Tsakris; Dimitris Rigopoulos
Journal:  Skin Appendage Disord       Date:  2015-05-28

Review 7.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

8.  Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors.

Authors:  Andreas Pinter; Georgios Kokolakis; Juergen Rech; Mona H C Biermann; Benjamin M Häberle; Jan Multmeier; Maximilian Reinhardt
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-04

Review 9.  Hidradenitis Suppurativa: Inside and Out.

Authors:  Sharmila Patil; Astuty Apurwa; Nitin Nadkarni; Shweta Agarwal; Parag Chaudhari; Manjyot Gautam
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494

10.  Hidradenitis Suppurativa (HS) prevalence, demographics and management pathways in Australia: A population-based cross-sectional study.

Authors:  Miriam Calao; Jodie L Wilson; Lynda Spelman; Laurent Billot; Diana Rubel; Alan D Watts; Gregor B E Jemec
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.